These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 19242528

  • 1. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.
    Hiasa A, Nishikawa H, Hirayama M, Kitano S, Okamoto S, Chono H, Yu SS, Mineno J, Tanaka Y, Minato N, Kato I, Shiku H.
    Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528
    [Abstract] [Full Text] [Related]

  • 2. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells.
    Hiasa A, Hirayama M, Nishikawa H, Kitano S, Nukaya I, Yu SS, Mineno J, Kato I, Shiku H.
    Gene Ther; 2008 May; 15(9):695-9. PubMed ID: 18288212
    [Abstract] [Full Text] [Related]

  • 3. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R, Ronteltap C, Heuveling M, Debets R, Bolhuis R.
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [Abstract] [Full Text] [Related]

  • 4. Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific alphabeta TCR genes.
    Ueno T, Fujiwara M, Tomiyama H, Onodera M, Takiguchi M.
    Eur J Immunol; 2004 Dec; 34(12):3379-88. PubMed ID: 15517606
    [Abstract] [Full Text] [Related]

  • 5. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT, Hagedoorn RS, van Loenen MM, Willemze R, Falkenburg JH, Heemskerk MH.
    Cancer Res; 2006 Mar 15; 66(6):3331-7. PubMed ID: 16540688
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ, Lyons GE, Kast WM, Yee C, Van Besien K, Nishimura MI.
    Cancer Res; 2005 Feb 15; 65(4):1570-6. PubMed ID: 15735047
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D, Rhinehart-Jones TR, Elkins KL.
    J Immunol; 1996 Dec 01; 157(11):5042-8. PubMed ID: 8943413
    [Abstract] [Full Text] [Related]

  • 11. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
    Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I.
    Cancer Res; 2009 Dec 01; 69(23):9003-11. PubMed ID: 19903853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.
    Willemsen RA, Weijtens ME, Ronteltap C, Eshhar Z, Gratama JW, Chames P, Bolhuis RL.
    Gene Ther; 2000 Aug 01; 7(16):1369-77. PubMed ID: 10981663
    [Abstract] [Full Text] [Related]

  • 14. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
    Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI.
    J Immunol; 1999 Jul 01; 163(1):507-13. PubMed ID: 10384155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Jul 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP, Urban FA, Macgregor JN, Hughes DP, McDonagh KT.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.